Exclusion criteria of breast cancer clinical trial protocols: a descriptive analysis.

Clara Wan Nicole E CastonStacey A IngramGabrielle Betty Rocque

Published in: Breast cancer research and treatment (2021)

Substantial heterogeneity was observed across laboratory values and comorbid variables among protocols. Future research should focus on defining standardized eligibility criteria while allowing for deviation based on drug specificity.

Keyphrases

clinical trial
single cell
cross sectional
current status
open label
phase ii
emergency department
study protocol
double blind
young adults
childhood cancer
breast cancer risk